PM

Pallavi Madan

Active Director Director DIN 09146075
DIN 09146075 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Pallavi Madan

Data last updated:

Pallavi Madan is a Director at Ehl Life Sciences Private Limited (since 2021). The company operates in Chemicals. Ehl Life Sciences Private Limited reported revenue of ₹26,920 (FY 2025).

DIN 09146075
Primary Designation Director
Industry Chemicals
First Appointment 14 Apr 2021
Oldest Company Age 5 yrs
Largest company Ehl Life Sciences Private Limited · ₹26,920 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ehl Life Sciences Private Limited U24240UP2021PTC145115
Director14 Apr 20212021₹26,920 (FY 2025)Active

Board colleagues of Pallavi Madan

Directorship timeline

Open interactive timeline →
Ehl Life Sciences Private Limited
Premium access

Shareholding and investment profile for Pallavi Madan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Madan

Pallavi Madan currently holds 1 directorship: Ehl Life Sciences Private Limited (Director, since 14 Apr 2021, revenue ₹26,920 (FY 2025)).

Pallavi Madan was first appointed on 14 Apr 2021 as Director at Ehl Life Sciences Private Limited.

The current boards of Pallavi Madan's companies include Sudershan Kumar Madan (Ehl Life Sciences Private Limited), Vineet Madan (Ehl Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available